Objectives: Pneumocystis jiroveci pneumonia is common in immunocompromised individuals.
Patients: This case report describes an immunosuppressed patient who acquired P jiroveci pneumonia 6 months after renal transplant surgery.
Results: The patient experienced many pneumonia-related complications and adverse effects from drug therapy, and despite treatment with various antibiotic agents, he died on the 62nd day after his admission to the intensive care unit.
Conclusions: The therapeutic failure of the drug of choice (co-trimoxazole) was evident. This case raises questions about the development of P jiroveci resistance to current therapies.